Inhibrx
INBX
INBX
101 hedge funds and large institutions have $172M invested in Inhibrx in 2024 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 31 increasing their positions, 29 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
5% more funds holding
Funds holding: 96 → 101 (+5)
7% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 29
Holders
101
Holding in Top 10
1
Calls
$1.28M
Puts
$418K
Top Buyers
1 | +$10.2M | |
2 | +$1.77M | |
3 | +$1.37M | |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.2M |
5 |
Goldman Sachs
New York
|
+$550K |
Top Sellers
1 | -$3.07M | |
2 | -$638K | |
3 | -$571K | |
4 |
Millennium Management
New York
|
-$477K |
5 |
Russell Investments Group
London,
United Kingdom
|
-$458K |